FDA declines to approve Alimera's eye drug, shares tank
The U.S. Food and Drug Administration declined to approve Alimera Sciences Inc's experimental drug to treat retinal swelling in its current form, sending the biopharmaceutical company's shares down 41 percent in after-market trade.
View full post on Yahoo! Health News
Alimera's, approve, Declines, drug, Shares, Tank